US Formula Industry Gets FTC's Antitrust Attention
Release Of Some Abbott EleCare, Kendmil Import From UK Get FDA OK
Executive Summary
Chairwoman Lina Khan was careful to note FTC isn’t investigating Abbott Nutrition’s manufacturing practices, its recall of products and shutdown of a plant and the supply shortage that followed.
You may also be interested in...
Urged By US FDA To Boost Infant Formula Supply, Additional Providers Still Must Wait For Approval
Patricia Hansen, CFSAN’s Office of Nutrition and Food Labeling deputy director and John Verbeten, deputy director for Import Operations Enforcement laid out the FDA's new enforcement guidance, and urged businesses with available formula to wait for approval before distributing formula in the US.
Biden Mandates Prioritizing Supplies For Infant Formula Production Over All Other Uses
Democrats and Republicans vote to approve $28m emergency finding for FDA formula programs proposed in bill introduced day earlier by Democrat leaders on Appropriations Committee. Biden deems Defense Production Act applicable to manufacturing formula products.
Merger Enforcement: FTC And Justice Department Casting Wide Net In Considering Changes
Agencies seek public comment on how they can modernize merger guidelines to enforce antitrust laws. List of questions, including what types of evidence show that a merger could reduce competition, indicate pharma and other mergers will face greater scrutiny.